Priya Karmali
32Patents
6h-index
49Co-inventors
65Inventor score
Filing activity: Mar 30, 2007 → May 31, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9011903B2 | Cationic lipids for therapeutic agent delivery formulations | Chemistry; Metallurgy | 22 | Active |
| US9242001B2 | Cationic lipids for therapeutic agent delivery formulations | Chemistry; Metallurgy | 10 | Active |
| US9963424B2 | Cationic lipids for therapeutic agent delivery formulations | Chemistry; Metallurgy | 8 | Active |
| US10526284B2 | Ionizable cationic lipid for RNA delivery | Chemistry; Metallurgy | 7 | Active |
| US8753604B2 | Methods and compositions for synaphically-targeted treatment for cancer | Performing Operations; Transporting | 7 | Active |
| US8956572B2 | Single use system for sterilely producing lipid-nucleic acid particles | Chemistry; Metallurgy | 6 | Active |
| US9308267B2 | Lipids for therapeutic agent delivery formulations | Emerging Cross-Sectional Technologies | 6 | Active |
| US10980895B2 | Ionizable cationic lipid for RNA delivery | Chemistry; Metallurgy | 5 | Active |
| US9579338B2 | Method of producing lipid nanoparticles for drug delivery | Chemistry; Metallurgy | 4 | Active |
| US10155945B2 | Method of producing lipid nanoparticles for drug delivery | Chemistry; Metallurgy | 3 | Active |
| US10383952B2 | Ionizable cationic lipid for RNA delivery | Chemistry; Metallurgy | 3 | Active |
| US10961188B2 | Ionizable cationic lipid for RNA delivery | Chemistry; Metallurgy | 3 | Active |
| US10441659B2 | Lipids for therapeutic agent delivery formulations | Emerging Cross-Sectional Technologies | 3 | Active |
| US10196637B2 | Retinoid-lipid drug carrier | Chemistry; Metallurgy | 3 | Active |
| US11084779B2 | Cationic lipids for therapeutic agent delivery formulations | Chemistry; Metallurgy | 2 | Active |
| US11744887B2 | Coronavirus vaccine compositions and methods | Emerging Cross-Sectional Technologies | 2 | Active |
| US11759515B2 | Compositions and methods for inducing immune responses | Emerging Cross-Sectional Technologies | 1 | Active |
| US11737979B2 | Method of making lipid-encapsulated RNA nanoparticles | Chemistry; Metallurgy | 1 | Active |
| US9403869B2 | α5β1 integrin binding RGD-lipopeptides with gene transfer activities | Human Necessities | 0 | Active |
| US12390524B2 | Compositions and methods for inducing immune responses | Emerging Cross-Sectional Technologies | 0 | Active |
| US12351834B2 | Compositions and methods for the treatment of ornithine transcarbamylase deficiency | Chemistry; Metallurgy | 0 | Active |
| US12178921B2 | Method of lyophilizing lipid nanoparticles | Human Necessities | 0 | Active |
| US11103583B2 | Lipids for therapeutic agent delivery formulations | Emerging Cross-Sectional Technologies | 0 | Active |
| US12220455B2 | Coronavirus vaccine compositions and methods | Emerging Cross-Sectional Technologies | 0 | Active |
| US12083224B2 | Lipid particles for nucleic acid delivery | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.